SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-013160
Filing Date
2019-04-26
Accepted
2019-04-25 19:34:59
Documents
6
Period of Report
2019-06-07
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A stro-def14a_20190607.htm DEF 14A 951666
2 GRAPHIC gt2f5guy00ep000002.jpg GRAPHIC 2071
3 GRAPHIC gt2f5guy00ep000003.jpg GRAPHIC 1976
4 GRAPHIC gt2f5guy00ep000005.jpg GRAPHIC 42754
5 GRAPHIC gt2f5guy00ep000004.jpg GRAPHIC 105028
6 GRAPHIC gt2f5guy00ep000001.jpg GRAPHIC 3376
  Complete submission text file 0001564590-19-013160.txt   1167282
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38662 | Film No.: 19768908
SIC: 2836 Biological Products, (No Diagnostic Substances)